Tag: Revance

Revance Announces FDA Approval of DAXXIFY

Revance Therapeutics, Inc., a biotechnology company focused on innovative aesthetic and therapeutic offerings, announced that the U.S. Food and Drug Administration (FDA) has approved DAXXIFY™ (DaxibotulinumtoxinA-lanm) for...

Read More
Loading

Login Status

January/February 2024 Issue

Upcoming Events

There are no upcoming events.